● Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

Condition: Antineutrophil Cytoplasmic Antibody-associated Vasculitis · Sponsor: Amgen

PhasePhase 4

Planned participants300

Who can joinAll sexes, 18 Years to 100 Years

Healthy volunteersNo

About this study

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

This description comes directly from the study's public registry record.

Talk to the study team

Amgen Call Center · 866-572-6436 · medinfo@amgen.com

Always discuss trial participation with your own doctor first.

Locations (83)

Orthopedic Physicians Alaska	Anchorage, Alaska, United States	Terminated
Scottsdale Healthcare at Shea - HonorHealth	Scottsdale, Arizona, United States	Recruiting
Southwest Kidney Institute	Surprise, Arizona, United States	Recruiting
Unity Health	Searcy, Arkansas, United States	Recruiting
Medvin Clinical Research	Covina, California, United States	Terminated
Palo Alto Medical Foundation Fremont	Fremont, California, United States	Recruiting
The Nephrology Group	Fresno, California, United States	Recruiting
Providence Medical Foundation	Fullerton, California, United States	Recruiting
Southland Arthritis and Osteoarthritis Medical Center, Inc	Menifee, California, United States	Recruiting
University of California San Francisco- Zuckerburg San Francisco General	San Francisco, California, United States	Recruiting
Harbor University of California at Los Angeles Medical Center	Torrance, California, United States	Recruiting
Amicis Research Center	Valencia, California, United States	Recruiting

+ 71 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06072482